BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24599428)

  • 1. Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication.
    Hydes T; Wright M; Jaynes E; Nash K
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24599428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liver cirrhosis due to chronic use of nitrofurantoin].
    Volbeda F; Jonker AM; Vecht J; Groeneveld PH
    Ned Tijdschr Geneeskd; 2004 Jan; 148(5):235-8. PubMed ID: 14983581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe nitrofurantoin-induced adverse drug reactions: Is there a benefit of sequential therapy?
    Benyamine A; Granel B; Belenotti P; Masson E; Default A; Garcia S; Serratrice J; Weiller PJ
    Therapie; 2019 Oct; 74(5):553-556. PubMed ID: 31027709
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nitrofurantoin-induced lupus-like syndrome associated with hepatitis].
    Salle V; Lafon B; Smail A; Cévallos R; Chatelain D; Andréjak M; Ducroix JP
    Rev Med Interne; 2006 Apr; 27(4):344-6. PubMed ID: 16364504
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrofurantoin-induced immune-mediated lung and liver disease.
    Milić R; Plavec G; Tufegdzić I; Tomić I; Sarac S; Loncarević O
    Vojnosanit Pregl; 2012 Jun; 69(6):536-40. PubMed ID: 22779302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune hepatitis triggered by nitrofurantoin: A rare drug-induced toxicity].
    Sorin B; Pineton de Chambrun M; Haroche J; Freund Y; Miyara M; Charlotte F; Lebrun-Vignes B; Amoura Z; Cohen Aubart F
    Rev Med Interne; 2016 Feb; 37(2):131-4. PubMed ID: 26404522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication.
    Sakaan SA; Twilla JD; Usery JB; Winton JC; Self TH
    South Med J; 2014 Feb; 107(2):107-13. PubMed ID: 24926677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal liver necrosis associated with the use of nitrofurantoin.
    Edoute Y; Karmon Y; Roguin A; Ben-Ami H
    Isr Med Assoc J; 2001 May; 3(5):382-3. PubMed ID: 11411208
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitrofurantoin and non-autoimmune hepatitis.
    Prieto de Paula JM; Martín-Luquero Ibáñez M; Franco Hidalgo S
    Med Clin (Barc); 2017 Apr; 148(8):382-383. PubMed ID: 28238334
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitrofurantoin-induced hepatotoxicity mediated by CD8+ T cells.
    Kelly BD; Heneghan MA; Bennani F; Connolly CE; O'Gorman TA
    Am J Gastroenterol; 1998 May; 93(5):819-21. PubMed ID: 9625135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrofurantoin-induced lung- and hepatotoxicity.
    Koulaouzidis A; Bhat S; Moschos J; Tan C; De Ramon A
    Ann Hepatol; 2007; 6(2):119-21. PubMed ID: 17519837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic toxicity of nitrofurantoin. Cases reported to the Center for Monitoring Adverse Drug Reactions 1968-1998].
    Dam-Larsen S; Kromann-Andersen H
    Ugeskr Laeger; 1999 Nov; 161(48):6650-2. PubMed ID: 10643355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney injury, hepatitis, and CPK elevation associated with nitrofurantoin therapy.
    Beigel R; Perets R; Mouallem M
    Am J Med Sci; 2009 Feb; 337(2):132-3. PubMed ID: 19214031
    [No Abstract]   [Full Text] [Related]  

  • 14. Nitrofurantoin toxicity to both liver and lungs.
    Yalçin S; Sahin A; Yalçin B; Altinok G
    Liver; 1997 Jun; 17(3):166-7. PubMed ID: 9249732
    [No Abstract]   [Full Text] [Related]  

  • 15. The risks of long-term nitrofurantoin prophylaxis in patients with recurrent urinary tract infection: a recent medico-legal case.
    Cetti RJ; Venn S; Woodhouse CR
    BJU Int; 2009 Mar; 103(5):567-9. PubMed ID: 18782308
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitrofurantoin-induced chronic active hepatitis.
    Amit G; Cohen P; Ackerman Z
    Isr Med Assoc J; 2002 Mar; 4(3):184-6. PubMed ID: 11908259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrofurantoin-induced immune-mediated lung and liver disease.
    Schattner A; Von der Walde J; Kozak N; Sokolovskaya N; Knobler H
    Am J Med Sci; 1999 May; 317(5):336-40. PubMed ID: 10334121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anicteric liver damage during nitrofurantoin medication.
    Klemola H; Penttilä O; Runeberg L; Tallqvist G
    Scand J Gastroenterol; 1975; 10(5):501-5. PubMed ID: 1153946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fatal hepatitis from nitrofurantoin].
    Baccino E; Mottier D; Pennec Y; Jouquan J; Youinou P; Le Guillou M
    Ann Gastroenterol Hepatol (Paris); 1985 Jan; 21(1):51-2. PubMed ID: 3977278
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced liver injury with autoimmune features.
    deLemos AS; Foureau DM; Jacobs C; Ahrens W; Russo MW; Bonkovsky HL
    Semin Liver Dis; 2014 May; 34(2):194-204. PubMed ID: 24879983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.